Publikationen, an denen er mitarbeitet Aikaterini Lalatsa (32)

2023

  1. 3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals

    Pharmaceutics, Vol. 15, Núm. 2

  2. Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating

    Pharmaceuticals, Vol. 16, Núm. 8

  3. Fomentando el emprendimiento universitario entre mujeres en disciplinas STEM

    Edunovatic2023. Conference Proceedings: 8th Virtual International Conference on Education, Innovation and ICT November 29 - 30, 2023

  4. Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis

    Pharmaceutics, Vol. 15, Núm. 11

  5. Women as Industry 4.0. entrepreneurs: unlocking the potential of entrepreneurship in Higher Education in STEM-related fields

    Journal of Innovation and Entrepreneurship, Vol. 12, Núm. 1

2022

  1. Microfluidic Manufacture of Lipid-Based Nanomedicines

    Pharmaceutics, Vol. 14, Núm. 9

  2. Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease

    Pharmaceutics, Vol. 14, Núm. 9

2021

  1. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms

    International Journal of Pharmaceutics, Vol. 597

  2. Engineering 3d printed microfluidic chips for the fabrication of nanomedicines

    Pharmaceutics, Vol. 13, Núm. 12

  3. Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts

    Pharmacological Research, Vol. 169

  4. Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis

    Journal of Immunology Research, Vol. 2021

  5. Understanding direct powder extrusion for fabrication of 3d printed personalised medicines: A case study for nifedipine minitablets

    Pharmaceutics, Vol. 13, Núm. 10

2020

  1. Personalised 3d printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms

    Pharmaceutics, Vol. 12, Núm. 4

  2. Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis

    International Journal of Pharmaceutics, Vol. 588

  3. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale

    International Journal of Pharmaceutics, Vol. 573

  4. Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases

    ACS Infectious Diseases, Vol. 6, Núm. 10, pp. 2647-2660

2019

  1. Designing fast-dissolving orodispersible films of amphotericin b for oropharyngeal candidiasis

    Pharmaceutics, Vol. 11, Núm. 8

  2. Market demands in 3D printing pharmaceuticals products

    3D Printing Technology in Nanomedicine (Elsevier), pp. 165-183

  3. Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis

    Pharmaceutics, Vol. 11, Núm. 7

  4. Technology-enhanced learning in higher education: How to enhance student engagement through blended learning

    European Journal of Education, Vol. 54, Núm. 2, pp. 273-286